VTYX vs. ERAS

Last updated Jun 4, 2026

VTYX (Ventyx Biosciences, Inc.) and ERAS (Erasca, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. At a 0.31 correlation, their price movements are largely independent.

Performance

VTYX vs. ERAS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ventyx Biosciences, Inc. (VTYX) and Erasca, Inc. (ERAS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

VTYX

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

ERAS

• 1D: -2.23%
• 1M: 29.98%
• YTD: 254.30%
• 6M: 300.61%
• 1Y: 812.11%
• 3Y*: 65.83%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

VTYX vs. ERAS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
VTYX Ventyx Biosciences, Inc.	55.04%	312.33%	-11.34%	-92.47%	65.11%	-5.52%
ERAS Erasca, Inc.	254.30%	48.21%	17.84%	-50.58%	-72.34%	-19.44%

Correlation

The correlation between VTYX and ERAS is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.26
Correlation (All Time) Calculated using the full available price history since Oct 22, 2021	0.31

The correlation between VTYX and ERAS shifts across timeframes, from 0.14 (1 year) to 0.31 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap VTYX : $998.26M ERAS : $4.01B
EPS VTYX : -$1.50 ERAS : -$0.96
PB Ratio VTYX : 5.22 ERAS : 10.19
Total Revenue (TTM) VTYX : $0.00 ERAS : $0.00
Gross Profit (TTM) VTYX : $0.00 ERAS : -$743.00K
EBITDA (TTM) VTYX : -$113.62M ERAS : -$279.47M

Return for Risk

VTYX vs. ERAS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ERAS

ERAS Risk / Return Rank: 98
ERAS Sharpe Ratio Rank: 100
ERAS Sortino Ratio Rank: 96
ERAS Omega Ratio Rank: 97
ERAS Calmar Ratio Rank: 98
ERAS Martin Ratio Rank: 99

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VTYX vs. ERAS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ventyx Biosciences, Inc. (VTYX) and Erasca, Inc. (ERAS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	VTYX	ERAS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	7.93	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.07	—

Drawdowns

Drawdown Indicators

	VTYX	ERAS	Difference
Max Drawdown Largest peak-to-trough decline	—	-95.65%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-59.46%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-67.88%	—
Current Drawdown Current decline from peak	—	-45.85%	—
Average Drawdown Average peak-to-trough decline	—	-74.89%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	18.00%	—

Volatility

Volatility by Period

	VTYX	ERAS	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	18.89%	—
Volatility (6M) Calculated over the trailing 6-month period	—	96.07%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	103.47%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	83.33%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	83.33%	—

Dividends

VTYX vs. ERAS - Dividend Comparison

Neither VTYX nor ERAS has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both VTYX and ERAS in my portfolio?

VTYX and ERAS have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.